Posaconazole in the management of refractory invasive fungal infections.

^*Korrespondierende/r Autor/-in für diese Arbeit

Publikation: Beitrag in Fachzeitschrift › Originalarbeit

Originalsprache	Englisch
Fachzeitschrift	Therapeutics and Clinical Risk Management
DOIs	https://doi.org/10.2147/TCRM.S3329
Publikationsstatus	Veröffentlicht - 2008

Wissenschaftszweige

@article{be88b6cf2369477bab6e0d5c99a525aa,

title = "Posaconazole in the management of refractory invasive fungal infections.",

author = "S Langner and Philipp Staber and Peter Neumeister",

year = "2008",

doi = "10.2147/TCRM.S3329",

language = "English",

journal = "Therapeutics and Clinical Risk Management",

issn = "1176-6336",

publisher = "Dove Medical Press Ltd",

}

TY - JOUR

T1 - Posaconazole in the management of refractory invasive fungal infections.

AU - Langner, S

AU - Staber, Philipp

A2 - Neumeister, Peter

PY - 2008

Y1 - 2008

UR - https://pubmed.ncbi.nlm.nih.gov/19209257

UR - https://pmc.ncbi.nlm.nih.gov/articles/PMC2621380

U2 - 10.2147/TCRM.S3329

DO - 10.2147/TCRM.S3329

M3 - Research article

C2 - 19209257

SN - 1176-6336

JO - Therapeutics and Clinical Risk Management

JF - Therapeutics and Clinical Risk Management

ER -